ASGE clinical practice update gives evidence-based recommendations on remimazolam, an ultra-short-acting benzodiazepine, for GI endoscopy sedation, covering efficacy, safety, dosing and patient selection versus midazolam and propofol.
Guideline
ASGE Standards of Practice Committee et al. Role of remimazolam in gastrointestinal endoscopy: American Society for Gastrointestinal Endoscopy clinical practice update